[HTML][HTML] Solid implantable devices for sustained drug delivery
E Magill, S Demartis, E Gavini, AD Permana… - Advanced Drug Delivery …, 2023 - Elsevier
Implantable drug delivery systems (IDDS) are an attractive alternative to conventional drug
administration routes. Oral and injectable drug administration are the most common routes …
administration routes. Oral and injectable drug administration are the most common routes …
Recent advances in “smart” delivery systems for extended drug release in cancer therapy
RV Kalaydina, K Bajwa, B Qorri, A Decarlo… - International journal …, 2018 - Taylor & Francis
Advances in nanomedicine have become indispensable for targeted drug delivery, early
detection, and increasingly personalized approaches to cancer treatment. Nanoparticle …
detection, and increasingly personalized approaches to cancer treatment. Nanoparticle …
Recent developments in Pickering emulsions for biomedical applications
Pickering emulsions, stabilised by organic or inorganic particles, offer long-term
dispersibility of liquid droplets and resistance to coalescence. The versatility of stabilising …
dispersibility of liquid droplets and resistance to coalescence. The versatility of stabilising …
Recent advancements of nanomedicine towards antiangiogenic therapy in cancer
A Mukherjee, VS Madamsetty, MK Paul… - International Journal of …, 2020 - mdpi.com
Angiogenesis is a process of generation of de-novo blood vessels from already existing
vasculature. It has a crucial role in different physiological process including wound healing …
vasculature. It has a crucial role in different physiological process including wound healing …
Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐and radioresistances
P Kola, PKB Nagesh, PK Roy, K Deepak… - Wiley …, 2023 - Wiley Online Library
The alarming increase in the number of breast cancer patients worldwide and the increasing
death rate indicate that the traditional and current medicines are insufficient to fight against …
death rate indicate that the traditional and current medicines are insufficient to fight against …
Recent advances in anti-angiogenic nanomedicines for cancer therapy
Angiogenesis is a normal physiological remodeling process initiated at the time of
embryonic development and lessened with the progress of time. Nevertheless, continuous …
embryonic development and lessened with the progress of time. Nevertheless, continuous …
A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder …
Abstract Coronavirus disease 2019 (COVID-19) is today's most serious epidemic disease
threatening the human race. The initial therapeutic approach of SARS-CoV-2 disease is …
threatening the human race. The initial therapeutic approach of SARS-CoV-2 disease is …
Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment
Breast cancer remains a leading global cause of morbidity and mortality. While the field of
immunotherapy is a promising avenue of investigation and has revolutionized the standard …
immunotherapy is a promising avenue of investigation and has revolutionized the standard …
Metamorphic effect of angiogenic switch in tumor development: conundrum of tumor angiogenesis toward progression and metastatic potential
Our understanding of angiogenesis has significantly expanded over the past five decades.
More recently, research has focused on this process at a more molecular level, looking at it …
More recently, research has focused on this process at a more molecular level, looking at it …
Therapeutic options for metastatic breast cancer
M Sambi, B Qorri, W Harless, MR Szewczuk - Breast cancer metastasis …, 2019 - Springer
Metastatic breast cancer is the most common cancer in women after skin cancer, with a 5-
year survival rate of 26%. Due to its high prevalence, it is important to develop therapies that …
year survival rate of 26%. Due to its high prevalence, it is important to develop therapies that …